Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells

  • Idit Dotan,
  • Philip J. R. Roche,
  • Michael Tamilia,
  • Miltiadis Paliouras,
  • Elliot J. Mitmaker,
  • Mark A. Trifiro
  • Article
  • Metrics
  • Comments
  • Media Coverage

Dr. Michael Tamilia is not included in the author byline. He should be listed as the third author and affiliated with Lady Davis Institute for Medical Research-Jewish General Hospital; Montreal, QC, Canada and Division of Endocrinology, Jewish General Hospital; Montreal, QC, Canada. The contributions of this author are as follows: Dr. Tamilia was involved in the very early process of the work describe in the paper, in both discussions and experimental design.

Reference

  1. 1. Dotan I, Roche PJR, Paliouras M, Mitmaker EJ, Trifiro MA (2016) Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS ONE 11(2): e0149723. pmid:26901566

Citation: Dotan I, Roche PJR, Tamilia M, Paliouras M, Mitmaker EJ, Trifiro MA (2016) Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS ONE 11(6): e0158022. https://doi.org/10.1371/journal.pone.0158022

Published: June 16, 2016

Copyright: © 2016 Dotan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.